… and to monitor post-marketing safety and adverse events. Citation7 In this study, we analyzed
the efficacy and safety of anlotinib in patients with advanced NSCLC in real-world settings. …

… cell lung cancer (NSCLC). The aim of this retrospective study was to investigate the efficacy
and safety of anlotinib … IIIB-IV) receiving anlotinib between November 2018 and February …

… Anlotinib is an oral novel multi-target tyrosine … stem cell factor receptor (c-Kit). The aim of
this study was to evaluate the efficacy and safety of anlotinib treatment in advanced lung cancer …

… In conclusion, we elucidated the efficacy and safety of anlotinib in a real-world setting. Anlotinib
is effective in the treatment of advanced NSCLC, which can bring longer survival benefits …

… performed, is safe, and can … anlotinib, and the efficacy and safety of the treatment were
assessed, with the primary observation endpoint being PFS. The results showed that anlotinib …

… Anlotinib is an anti-angiogenetic multi-targeted tyrosine … and safety of anlotinib in advanced
non-small cell lung cancer (… , anlotinib combination therapy improved survival and tumor …

… However, in practice, anlotinib is used not only in third-… anlotinib in SCLC at the frontline.
Therefore, this study aimed to analyze real-world data on anlotinib to evaluate whether anlotinib …

… safety of anlotinib as a third-line and subsequent treatment for patients with small cell lung
cancer … trial to compare the efficacy and safety of anlotinib monotherapy vs placebo as the third…

… the efficacy of using Anlotinib in the second-line or further treatment of lung cancer in the
real-… Results: Of 167 patients were enrolled in this study, 106 were in Anlotinib group and 61 …

… : Anlotinib, an … safety in treating extensive-stage small cell lung cancer (ES-SCLC) in some
clinical studies. This research aimed to explore the real-world efficacy and safety of anlotinib …